Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06323265
What this trial is testing

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Hebei Medical University Fourth Hospital 50
Large-scale testing (Phase 3)Study completedNCT04005716
What this trial is testing

Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
BeiGene 457
Early research (Phase 1)Study completedNCT03085849
What this trial is testing

SGI-110 Plus Durvalumab/Tremelimumab in SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Catherine Shu 2
Testing effectiveness (Phase 2)Ended earlyNCT04101357
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

Who this might be right for
Solid TumorExtensive-stage Small Cell Lung Cancer
BioNTech SE 54
Early research (Phase 1)Active Not RecruitingNCT05353439
What this trial is testing

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaPlatinum-Resistant Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT06726148
What this trial is testing

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsExtensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals 280
Not applicableUnknownNCT06530797
What this trial is testing

Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Pulmonary Hospital, Shanghai, China 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06429696
What this trial is testing

PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University 40
Early research (Phase 1)Looking for participantsNCT07113691
What this trial is testing

Iadademstat + SBRT With Atezo in ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Yale University 15
Large-scale testing (Phase 3)Study completedNCT00363415
What this trial is testing

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 908
Early research (Phase 1)Active Not RecruitingNCT05595460
What this trial is testing

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Who this might be right for
SCLC,Extensive Stage
RayzeBio, Inc. 21
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Looking for participantsNCT07391813
What this trial is testing

SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)
SN BioScience 55
Testing effectiveness (Phase 2)Looking for participantsNCT07245446
What this trial is testing

Ivonescimab in First-Line ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso 180
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06816966
What this trial is testing

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

Who this might be right for
Small-cell Lung Cancer
Fujian Medical University Union Hospital 35
Early research (Phase 1)Looking for participantsNCT07413042
What this trial is testing

A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

Who this might be right for
SCLC, Extensive Stage
Peking University Cancer Hospital & Institute 24
Testing effectiveness (Phase 2)Study completedNCT00066313
What this trial is testing

ZD6474 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Genzyme, a Sanofi Company
Early research (Phase 1)Active Not RecruitingNCT07009457
What this trial is testing

A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Widespread Small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 24
Testing effectiveness (Phase 2)UnknownNCT02179528
What this trial is testing

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Peking University Cancer Hospital & Institute 210
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Next Page